Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome.

摘要

We read with great interest the article by Sato et al., recently published in Pediatric Nephrology, who presented a patient with atypical Pneumocystis jiroveci pneumonia (PCP) with multiple nodular granulomas after rituximab therapy for refractory nephrotic syndrome [1]. We would like to present a case of our patient who, interestingly, revealed a different clinical course compared with that described by Sato and colleagues.